The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Gout Arthritis (Internal Medicine Management)

Acute attack and chronic urate-lowering therapy: contemporary EULAR/ACR algorithm

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Gout Arthritis (Internal Medicine Management)?

Gout is a metabolic disease leading to recurrent acute arthritis attacks, tophus formation, and chronic destructive arthropathy in the setting of persistent hyperuricemia. Prevalence is 3-6% in men and 1-2% in women; rising due to obesity, alcohol, and modern dietary patterns.

Acute attacks are usually monoarticular, presenting with sudden severe pain, swelling, and erythema in the first metatarsophalangeal joint (podagra). Diagnosis: identification of MSU crystals (negatively birefringent needle-shaped) under polarized microscopy in synovial fluid is the gold standard.

EULAR 2016 and ACR 2020 guidelines recommend urate-lowering therapy in patients with two or more attacks per year, tophi, urate stones, or stage 2-5 CKD. First line: allopurinol (start at 100 mg/day, titrate up to 300-800 mg). Second line: febuxostat (40-80 mg/day).

Symptoms

Sudden severe joint pain (often nocturnal onset)
First MTP joint redness, swelling, warmth (podagra)
Severe pain (cannot tolerate even bedsheet contact)
Knee, ankle, elbow attacks (less common locations)
Tophi (in chronic disease - earlobe, olecranon, finger joints)
Low-grade fever and malaise

Risk Factors

Male gender and postmenopausal women
Hyperuricemia (>6.8 mg/dL)
Obesity, hypertension, metabolic syndrome
Alcohol (especially beer) and fructose-rich beverages
Diuretics (thiazide, loop) and low-dose aspirin
Chronic kidney disease and family history

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Sudden onset acute mono/oligoarthritis
  • Joint redness, swelling, severe pain
  • Recurrent attacks (2+ per year)
  • Tophus and joint deformity
  • Renal stone history with urate stones
  • Persistent hyperuricemia (>9 mg/dL)

Treatment Methods

01
Acute attack: NSAID (naproxen, indomethacin) - first 24h
02
Colchicine (1.2 mg + 0.6 mg after 1h) - first 36h
03
Intra-articular/oral steroid (NSAID-contraindicated)
04
Urate-lowering: allopurinol (titrate to target <6 mg/dL)
05
Febuxostat (in severe renal impairment, allopurinol intolerance)
06
Diet: alcohol, organ meats, seafood restriction

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.